Mycoplasma Testing Market Research Report Information By Product (Kits & Reagents, Instruments, Services), Technique (DNA, PCR, ELISA, Direct, Indirect Assay), Application (cell line testing, virus testing), End user (CRO, Cell banks) - Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

Chapter 6. Global Mycoplasma Testing Market, by Product

6.1 Introduction

6.2 Kits & Reagents

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3 Instruments

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4 Services

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

Chapter 7. Global Mycoplasma Testing Market, by Technology

7.1 Introduction

7.2 DNA Stain

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3 Enzyme-based

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4 PCR

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.5 ELISA

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.6 Direct Assay

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.7 Direct Assay

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.8 Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

Chapter 8. Global Mycoplasma Testing Market, by Application

8.1 Introduction

8.2 Cell Line and Cell Therapy Testing

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.3 Virus Testing

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.4 Row Material Testing

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.5 Lot Material Testing

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.6 Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

Chapter 9. Global Mycoplasma Testing Market, by End User

9.1 Introduction

9.2 Pharmaceutical and Biological Manufacturing

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.3 Contract Research Organizations

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.4 Cell Banks

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.5 Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

Chapter 10. Global Mycoplasma Testing Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Charles River Laboratories, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Merck KGaA

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Lonza Group Ltd

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Roche Diagnostics

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 SGS S.A.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 American Type Culture Collection

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Invivogen

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Wuxi Apptec

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Promocell GmbH

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Thermo Fisher Scientific Inc.

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Mycoplasma Testing Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Mycoplasma Testing Market Synopsis, 2022-2030

Table 2 Global Mycoplasma Testing Market Estimates and Forecast, 2022-2030 (USD Billion)

Table 3 Global Mycoplasma Testing Market, by Region, 2022-2030 (USD Billion)

Table 4 Global Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 5 Global Mycoplasma Testing Market, by Technique, 2022-2030 (USD Billion)

Table 6 Global Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 7 Global Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 8 North America: Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 9 North America: Mycoplasma Testing Market, by Technique, 2022-2030 (USD Billion)

Table 10 North America: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 11 North America: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 12 US: Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 13 US: Mycoplasma Testing Market, by Technique, 2022-2030 (USD Billion)

Table 14 US: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 15 US: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 16 Canada: Mycoplasma Testing Market,by Product, 2022-2030 (USD Billion)

Table 17 Canada: Mycoplasma Testing Market,by Technique, 2022-2030 (USD Billion)

Table 18 Canada: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 19 Canada: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 20 South America: Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 21 South America: Mycoplasma Testing Market, by Technique, 2022-2030 (USD Billion)

Table 22 South America: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 23 South America: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 24 Europe: Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 25 Europe: Mycoplasma Testing Market, by Technique, 2022-2030 (USD Billion)

Table 26 Europe: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 27 Europe: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 28 Western Europe: Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 29 Western Europe: Mycoplasma Testing Market, by Technique, 2022-2030

(USD Billion)

Table 30 Western Europe: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 31 Western Europe: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 32 Eastern Europe: Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 33 Eastern Europe: Mycoplasma Testing Market, by Technique, 2022-2030 (USD Billion)

Table 34 Eastern Europe: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 35 Eastern Europe: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 36 Asia-Pacific: Mycoplasma Testing Market, by Product, 2022-2030 (USD Billion)

Table 37 Asia-Pacific: Mycoplasma Testing Market, by Technique, 2022-2030 (USD Billion)

Table 38 Asia-Pacific: Mycoplasma Testing Market, by Application, 2022-2030 (USD Billion)

Table 39 Asia-Pacific: Mycoplasma Testing Market, by End User, 2022-2030 (USD Billion)

Table 40 Middle East & Africa: Mycoplasma Testing Market, by Product, 2022-2030

(USD Billion)

Table 41 Middle East & Africa: Mycoplasma Testing Market, by Technique, 2022-2030

(USD Billion)

Table 42 Middle East & Africa: Mycoplasma Testing Market, by Application, 2022–

2030 (USD Billion)

Table 43 Middle East & Africa: Mycoplasma Testing Market, by End User, 2022–

2030 (USD Billion)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Mycoplasma Testing Market

Figure 3 Segmentation Market Dynamics for Global Mycoplasma Testing Market

Figure 4 Global Mycoplasma Testing Market Share, by Product, 2022

Figure 5 Global Mycoplasma Testing Market Share, by Technique, 2022

Figure 6 Global Mycoplasma Testing Market Share, by Application, 2022

Figure 7 Global Mycoplasma Testing Market Share, by End User, 2022

Figure 8 Global Mycoplasma Testing Market Share, by Region, 2022

Figure 9 North America: Mycoplasma Testing Market Share, by Country, 2022

Figure 10 Europe: Mycoplasma Testing Market Share, by Country, 2022

Figure 11 Asia-Pacific: Mycoplasma Testing Market Share, by Country, 2022

Figure 12 Middle East & Africa: Mycoplasma Testing Market Share, by Country, 2022

Figure 13 Global Mycoplasma Testing Market: Company Share Analysis, 2022 (%)

Figure 14 Charles River Laboratories, Inc : Key Financials

Figure 15 Charles River Laboratories, Inc : Segmental Revenue

Figure 16 Charles River Laboratories, Inc : Geographical Revenue

Figure 17 Merck KGaA: Key Financials

Figure 18 Merck KGaA: Segmental Revenue

Figure 19 Merck KGaA: Geographical Revenue

Figure 20 Lonza Group Ltd: Key Financials

Figure 21 Lonza Group Ltd: Segmental Revenue

Figure 22 Lonza Group Ltd: Geographical Revenue

Figure 23 Roche Diagnostics: Key Financials

Figure 24 Roche Diagnostics: Segmental Revenue

Figure 25 Roche Diagnostics: Geographical Revenue

Figure 26 SGS S.A.: Key Financials

Figure 27 SGS S.A.: Segmental Revenue

Figure 28 SGS S.A.. Geographical Revenue

Figure 29 American Type Culture Collection: Key Financials

Figure 30 American Type Culture Collection: Segmental Revenue

Figure 31 American Type Culture Collection: Geographical Revenue

Figure 32 Invivogen: Key Financials

Figure 33 Invivogen: Segmental Revenue

Figure 34 Invivogen: Geographical Revenue

Figure 35 Wuxi Apptec: Key Financials

Figure 36 Wuxi Apptec: Segmental Revenue

Figure 37 Wuxi Apptec: Geographical Revenue

Figure 38 Thermo Fisher Scientific Inc: Key Financials

Figure 39 Thermo Fisher Scientific Inc: Segmental Revenue

Figure 40 Thermo Fisher Scientific Inc: Geographical Revenue

Figure 41 Promocell GmbH: Key Financials

Figure 42 Promocell GmbH: Segmental Revenue

Figure 43 Promocell GmbH: Geographical Revenue